15.07.2016 AURELIUS SE & Co. KGaA  DE000A0JK2A8

DGAP-News: AURELIUS Group acquires cosmetic clinic operator 'The Hospital Group'


 
DGAP-News: AURELIUS SE & Co. KGaA / Key word(s): Takeover AURELIUS Group acquires cosmetic clinic operator 'The Hospital Group' 15.07.2016 / 07:00 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- AURELIUS Group acquires cosmetic clinic operator "The Hospital Group" - Provider of surgical and non-surgical cosmetic procedures - Complex shareholder circumstances present valuable equity acquisition opportunity - Large synergy potential with AURELIUS Group's established acquisition Transform Munich / London - July 15, 2016 - AURELIUS Group (ISIN DE000A0JK2A8) today announces the acquisition of "The Hospital Group", a provider of surgical and non-surgical cosmetic procedures based in Birmingham, UK. With approximately 300 employees, The Hospital Group generated revenues of almost EUR 40 million in 2015. The financial terms of the transaction are undisclosed. The Hospital Group is a leading provider of cosmetic procedures in the UK, as well as a market leader in weight loss treatments. The Company operates the largest cosmetic surgery hospital in Europe together with 15 clinics across Great Britain. The Hospital Group boasts high patient satisfaction rates in its four business areas of cosmetic surgery, weight loss, cosmetic dentistry, and non-surgical treatments. There is significant potential for large revenue and cost synergies between The Hospital Group and Transform Group, which was acquired by AURELIUS in July 2015. Transform, which comprises 27 clinics across the UK and two dedicated cosmetic surgery hospitals in Manchester and London, is the domestic market leader in cosmetic surgery. "With the acquisition of The Hospital Group and Transform, we have reached a leading position in the British market for cosmetic surgery and treatment. We see large growth potential in this market for the coming years," commented Gerhard Engleder, vice president of AURELIUS Group. ABOUT AURELIUS AURELIUS is one of the leading European investment groups. From its offices in Munich, London, Stockholm and Madrid, AURELIUS acquires participations with development potential. Once under the AURELIUS umbrella, the acquisitions are given a long-term strategic orientation in order for them to fully develop their potential. Currently, the AURELIUS Group consists of 25 subsidiaries with locations in Europe, Asia, and the U.S.A. These include numerous traditional consumer brands, services businesses and a number of industrial enterprises. Companies are acquired based on strict investment criteria without focusing on any particular industry. Shares of AURELIUS Equity Opportunities SE & Co. KGaA are listed in the m:access segment of the Munich Stock Exchange and are traded on all German stock markets under ISIN DE000A0JK2A8. To find out more, visit www.aureliusinvest.com CONTACT Anke Banaschewski Investor Relations & Corporate Communications Phone +49 (89) 544799 - 0 Fax +49 (89) 544799 - 55 [email protected] --------------------------------------------------------------------------- 15.07.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: AURELIUS SE & Co. KGaA Ludwig-Ganghofer-Straße 6 82031 Grünwald Germany Phone: +49 (0)89 544 799-0 Fax: +49 (0)89 544 799-55 E-mail: [email protected] Internet: www.aureliusinvest.de ISIN: DE000A0JK2A8 WKN: A0JK2A Listed: Regulated Unofficial Market in Berlin, Munich, Stuttgart; Open Market in Frankfurt End of News DGAP News Service --------------------------------------------------------------------------- 482657 15.07.2016


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 2.998,35 2.902,94 3.612,00 1.932,90 2.560,80 2.995,00 0,00
EBITDA1,2 272,56 65,72 80,30 167,60 249,70 154,40 0,00
EBITDA-Marge3 9,09 2,26 2,22 8,67 9,75 5,16
EBIT1,4 202,00 11,69 -84,20 222,70 115,80 29,40 0,00
EBIT-Marge5 6,74 0,40 -2,33 11,52 4,52 0,98 0,00
Jahresüberschuss1 484,49 -39,52 18,27 121,60 151,80 78,70 0,00
Netto-Marge6 16,16 -1,36 0,51 6,29 5,93 2,63 0,00
Cashflow1,7 -132,16 -50,00 -76,10 227,50 42,90 -41,50 0,00
Ergebnis je Aktie8 5,98 -1,43 -3,43 3,62 4,86 2,99 1,65
Dividende8 5,00 3,00 0,00 1,00 1,50 0,05 4,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Aurelius Equity Opportunities
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0JK2A 14,620 Halten 398,69
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
7,31 7,86 0,94 7,31
KBV KCV KUV EV/EBITDA
0,66 - 0,13 3,15
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,05 0,25 1,71 20.09.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
11.05.2023 10.08.2023 10.11.2022 27.03.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-1,73% 6,09% 7,50% -6,16%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu AURELIUS SE & Co. KGaA  ISIN: DE000A0JK2A8 können Sie bei EQS abrufen


Beteiligungen , A0JK2A , AR4 , HAM:AR4